Skip to main content
SpringerLink
Log in

Pathogenesis of Hypertension: Genetic and Environmental Factors

  • Chapter
Atlas of Heart Diseases

Part of the book series: Atlas of Heart Diseases ((AD))

  • 203 Accesses

Abstract

Like obesity and diabetes, essential hypertension is one of the “diseases of civilization” that results from the collision of a modern lifestyle with Paleolithic genes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Platt R: Heredity in hypertension. Q J Med 1947, 16: 111–113.

    PubMed  CAS  Google Scholar 

  2. Pickering GW: The genetic factor in essential hypertension. Ann Intern Med 1955, 43: 457–464.

    PubMed  CAS  Google Scholar 

  3. Ledingham JM: Genetics of human hypertension. In Hypertensive Cardiovascular Disease: Pathophysiology and Treatment. Edited by Amery A. The Hague/Boston/London: Martinus Nijhoff Publishers 1982: 206–216.

    Chapter  Google Scholar 

  4. Mongeau J-G, Brion P, Sing CF: The influence of genetics and household environment upon the variability of normal blood pressure: the Montreal Adoption Survey. Clin Exp Hypertens [A] 1986, 8: 653–660.

    Article  CAS  Google Scholar 

  5. Tambs K, Eaves LJ, Mourn T, et al.: Age-specific genetic effects for blood pressure. Hypertension 1993, 22: 789–795.

    Article  PubMed  CAS  Google Scholar 

  6. Ward R: Familial aggregation and genetic epidemiology of blood pressure. In Hypertension: Pathophysiology, Diagnosis, and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press Ltd; 1990: 81–100.

    Google Scholar 

  7. Schork NJ, Jokelainen P, Grant EJ, et al.: Relationship of growth and blood pressure in inbred rats. Am J Physiol 1994, 266: R702–R708.

    PubMed  CAS  Google Scholar 

  8. St. Lezin E, Simonet L, Pravenec M, et al.: Hypertensive strains and normotensive “control” strains: how closely are they related? Hypertension 1992, 19: 419–424.

    Article  PubMed  CAS  Google Scholar 

  9. Bruner CA, Myers JH, Sing CF, et al.: Genetic association of hypertension and vascular changes in stroke-prone spontaneously hypertensive rats. Hypertension 1986, 8: 904–910.

    Article  PubMed  CAS  Google Scholar 

  10. Rapp JP: Characteristics of Dahl salt-susceptible and salt-resistant rats. In Handbook of Hypertension. Vol 4. Experimental and Genetic Models of Hypertension. Edited by de Jong W. New York: Elsevier Science Publishers; 1984: 286–295.

    Google Scholar 

  11. Harrap SB, Van Der Merwe WM, Griffin SA, et al.: Brief angiotensin-converting enzyme inhibitor treatment in young spontaneously hypertensive rats reduces blood pressure long-term. Hypertension 1990, 16: 603–614.

    Article  PubMed  CAS  Google Scholar 

  12. Jacob HJ, Lindpaintner K, Lincoln SE, et al.: Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 1991, 67: 213–224.

    Article  PubMed  CAS  Google Scholar 

  13. Hilbert P, Lindpaintner K, Beckmann JS, et al.: Chromosomal mapping of two genetic loci associated with blood-pressure regulation in hereditary hypertensive rats. Nature 1991, 353: 521–529.

    Article  PubMed  CAS  Google Scholar 

  14. Rapp JP, Wang S-M, Dene H: A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 1989, 243: 542–544.

    Article  PubMed  CAS  Google Scholar 

  15. St. Lezin EM, Pravenec M, Kurtz TW: New genetic models for hypertension research. Trends Cardiovasc Med 1993, 3: 119–123.

    Article  CAS  Google Scholar 

  16. Ely DL, Daneshvar H, Turner ME, et al.: The hypertensive Y chromosome elevates blood pressure in F11 normotensive rats. Hypertension 1993, 21: 1071–1075.

    Article  PubMed  CAS  Google Scholar 

  17. Ganten D, Lindpaintner K, Ganten U, et al.: Transgenic rats: new animal models in hypertension research. Hypertension 1991, 17: 843–855.

    Article  PubMed  CAS  Google Scholar 

  18. Mullins JJ, Peters J, Ganten D: Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990, 344: 541–544.

    Article  PubMed  CAS  Google Scholar 

  19. Williams RR, Hunt SC, Hasstedt SJ, et al.: Definition of genetic factors in hypertension: a search for major genes, polygenes, and homogeneous subtypes. J Cardiovasc Pharmacol 1988, 12(suppl 3): S7–S20.

    PubMed  Google Scholar 

  20. Lifton RP, Dluhy RG, Powers M, et al.: A chimaeric 11ß-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 1992, 355: 262–265.

    Article  PubMed  CAS  Google Scholar 

  21. White R, Lalouel J-M: Chromosomal mapping with DNA markers. Sci Am 1988, 258: 40–48.

    Article  PubMed  CAS  Google Scholar 

  22. Schuster H, Wienker TF, Bähring S, et al.: Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet, 1996; 13: 98–100.

    Article  PubMed  CAS  Google Scholar 

  23. Liddle GW, Bledsoe T, Coppage WS: Aldosteronism but with negligible aldosterone secretion. Trans Am Assoc Physiol 1963, 76: 199–213.

    CAS  Google Scholar 

  24. Botero-Velez M, Curtis JJ, Warnock DG: Brief report: Liddle’s syndrome revisited: a disorder of sodium resorption in the distal tubule. N Engl J Med 1994, 330: 178–181.

    Article  PubMed  CAS  Google Scholar 

  25. Shimkets RA, Warnock DG, Bositis CM, et al.: Liddle’s syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell 1994, 79: 407–414.

    Article  PubMed  CAS  Google Scholar 

  26. Hansson JH, Nelson-Williams C, Suzuki H, et al.: Hypertension caused by a truncated epithelial sodium channel gamma subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 1995, 11: 76–82.

    Article  PubMed  CAS  Google Scholar 

  27. Hansson JH, Schild L, Lu Y, et al.: A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci USA 1995, 92: 11495–11499.

    Article  PubMed  CAS  Google Scholar 

  28. Schild L, Canessa CM, Shimkets RA, et al.: A mutation in the epithelial sodium channel causing Liddle disease increases channel activity in the Xenopus laevis oocyte expression system. Proc Natl Acad Sci USA 1995, 92: 5699–5703.

    Article  PubMed  CAS  Google Scholar 

  29. Lifton RP: Molecular genetics of human blood pressure variation. Science 1996, 272: 676–680.

    Article  PubMed  CAS  Google Scholar 

  30. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71: 1–20.

    Article  Google Scholar 

  31. Ward K, Hata A, Jeunemaitre X, et al.: A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 1993, 4: 59–61.

    Article  PubMed  CAS  Google Scholar 

  32. Inoue I, Nakajima T, Williams CS, et al.: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 1997, 99: 1786–1797.

    Article  PubMed  CAS  Google Scholar 

  33. Casari G, Barlassina C, Cusi D, et al.: Association of the alpha-adducin locus with essential hypertension. Hypertension 1995, 25: 320–326.

    Article  PubMed  CAS  Google Scholar 

  34. Cusi D, Barlassina T, Azzani T, et al.: Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997, 349: 1353–1357.

    Article  PubMed  CAS  Google Scholar 

  35. Weder AB: Membrane sodium transport. In Hypertension Primer. The Essentials of High Blood Pressure. Edited by Izzo JL, Black HR. Dallas: American Heart Association; 1993: 36–37.

    Google Scholar 

  36. Blaustein M: Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol 1977, 232: 065–073.

    Google Scholar 

  37. Haddy FJ: Potassium, Na+-K+ pump inhibitor and low-renin hypertension. Clin Invest Med 1987, 10: 547–554.

    PubMed  CAS  Google Scholar 

  38. Canessa ML, Adragna NC, Solomon HS, et al.: Increased lithium-sodium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980, 302: 772–776.

    Article  PubMed  CAS  Google Scholar 

  39. Camussi A, Bianchi G: Genetics of essential hypertension: from the unimodal-bimodal controversy to molecular technology. Hypertension 1988, 12: 620–628.

    Article  PubMed  CAS  Google Scholar 

  40. Canessa ML, Morgan K, Semplicini A: Genetic differences in lithium-sodium exchange and regulation of the sodium-hydrogen exchanger in essential hypertension. J Cardiovasc Pharmacol 1988, 12(suppl 3): 92–98.

    Google Scholar 

  41. Weder AB: Red-cell lithium-sodium countertransport and renal lithium clearance in hypertension. N Engl J Med 1986, 314: 198–201.

    Article  PubMed  CAS  Google Scholar 

  42. Redgrave J, Canessa M, Gleason R, et al.: Red blood cell lithium-sodium countertransport in non-modulating essential hypertension. Hypertension 1989, 13: 721–726.

    Article  PubMed  CAS  Google Scholar 

  43. Doria A, Fioretto P, Avogaro A, et al.: Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 1991, 261: E684–E691.

    PubMed  CAS  Google Scholar 

  44. Lifton RP, Hunt SC, Williams RR, et al.: Exclusion of the Na+-H+ antiporter as a candidate gene in human essential hypertension. Hypertension 1991, 17: 8–14.

    Article  PubMed  CAS  Google Scholar 

  45. Julius S, Jamerson K, Meija A, et al.: The association of borderline hypertension with target organ changes and higher coronary risk: Tecumseh Blood Pressure Study. JAMA 1990, 264: 354–358.

    Article  PubMed  CAS  Google Scholar 

  46. Williams RR, Hunt SC, Hopkins PN, et al.: Familial dyslipidemic hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA 1988, 259: 3579–3586.

    Article  PubMed  CAS  Google Scholar 

  47. Williams RR, Hopkins PN, Hunt SC, et al.: Population-based frequency of dyslipidemic syndromes in coronary-prone families in Utah. Arch Intern Med 1990, 150: 582–588.

    Article  PubMed  CAS  Google Scholar 

  48. Wallin G, Kunimoto MM, Sellgren J: Possible genetic influence on the strength of human muscle nerve sympathetic activity at rest. Hypertension 1993, 22: 282–284.

    Article  PubMed  CAS  Google Scholar 

  49. Williams GH, Dluhy RG, Lifton RP, et al.: Non-modulation as an intermediate phenotype in essential hypertension. Hypertension 1992, 20: 788–796.

    Article  PubMed  CAS  Google Scholar 

  50. Rose G: Population distributions of risk and disease. Nutr Metab Cardiovasc Dis 1991, 1: 37–40.

    Google Scholar 

  51. INTERSALT Cooperative Research Group: INTERSALT: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. BMJ 1988, 297: 319–328.

    Article  Google Scholar 

  52. Rose G, Day S: The population mean predicts the number of deviant individuals. BMJ 1990, 301: 1031–1034.

    Article  PubMed  CAS  Google Scholar 

  53. Denton D, Weisinger R, Mundy NI, et al.: The effect of increased salt intake on blood pressure of chimpanzees. Nat Med 1995, 1: 1009–1016.

    Article  PubMed  CAS  Google Scholar 

  54. McCarron DA, Morris CD, Henry HJ, et al.: Blood pressure and nutrient intake in the United States. Science 1984, 224: 1392–1398.

    Article  PubMed  CAS  Google Scholar 

  55. Witteman JCM, Willett WC, Stampfer MJ, et al.: A prospective study of nutritional factors and hypertension among US women. Circulation 1989, 80: 1320–1327.

    Article  PubMed  CAS  Google Scholar 

  56. Resnick LM, Gupta RK, Bhargava KK: Cellular electrolytes in hypertension, diabetes, and obesity: a nuclear magnetic resonance spectroscopic study. Hypertension 1991, 17: 951–957.

    Article  PubMed  CAS  Google Scholar 

  57. Resnick LM: Calciotropic hormones in human and experimental hypertension. Am J Hypertens 1990, 3(suppl): 171–178.

    Google Scholar 

  58. Gruchow HW, Sobocinski KA, Barboriak JJ: Calcium intake and the relationship of dietary sodium and potassium to blood pressure. Am J Clin Nutr 1988, 48: 1463–1470.

    PubMed  CAS  Google Scholar 

  59. Criqui MH, Langer RD, Reed DM: Dietary alcohol, calcium, and potassium: independent and combined effects on blood pressure. Circulation 1989, 80: 609–614.

    Article  PubMed  CAS  Google Scholar 

  60. Green LW: Manual for scoring socioeconomic status for research on health behavior. Public Health Rep 1970, 85: 815–827.

    Article  PubMed  CAS  Google Scholar 

  61. Klag MJ, Whelton PK, Coresh J, et al.: The association of skin color with blood pressure in US blacks with low socioeconomic status. JAMA 1991, 265: 599–602.

    Article  PubMed  CAS  Google Scholar 

  62. Simopoulos AP: Dietary risk factors for hypertension. Comp Ther 1992, 18: 26–30.

    CAS  Google Scholar 

  63. Eaton SB, Konner M, Shostak M: Stone agers in the fast lane: chronic degenerative diseases in evolutionary perspective. Am J Med 1988, 84: 739–749.

    Article  PubMed  CAS  Google Scholar 

  64. Stamler J, Rose G, Elliott P, et al.: Findings of the international cooperative INTERSALT study. Hypertension 1991, 17(suppl I): 9–15.

    Article  Google Scholar 

  65. Wilson TW, Grim CE: Biohistory of slavery and blood pressure differences in blacks today: a hypothesis. Hypertension 1991, 17(suppl I): 122–128.

    Article  Google Scholar 

  66. Jackson FLC: An evolutionary perspective on salt, hypertension, and human genetic variability. Hypertension 1991, 17(suppl I): 129–132.

    Article  Google Scholar 

  67. Grobbee DE: Methodology of sodium sensitivity assessment: the example of age and sex. Hypertension 1991, 17(suppl I): 109–114.

    Article  Google Scholar 

  68. Grobbee DE, Hofman A: Does sodium restriction lower blood pressure? BMJ 1986, 293: 27–29.

    Article  PubMed  CAS  Google Scholar 

  69. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153: 154–183.

    Article  Google Scholar 

  70. Midgley JP, Matthew AG, Greenwood CMT, Logan AG: Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996, 275: 1590–1597.

    Article  PubMed  CAS  Google Scholar 

  71. Hollenberg NK, Martinez G, McCullough M, et al.: Aging, acculturation, salt intake, and hypertension in the Kuna of Panama. Hypertension 1997, 171–176.

    Google Scholar 

  72. Krishna GG, Miller E, Kapoor S: Increased blood pressure during potassium depletion in normotensive men. N Engl J Med 1989, 320: 1177–1182.

    Article  PubMed  CAS  Google Scholar 

  73. Appel LJ, Moore TJ, Obarzanek E, et al.: A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997, 336: 1117–1124.

    Article  PubMed  CAS  Google Scholar 

  74. Grobbee DE, Waal-Manning HJ: The role of calcium supplementation in the treatment of hypertension: current evidence. Drugs 1990, 39: 7–18.

    Article  PubMed  CAS  Google Scholar 

  75. Barker DJP, Bull AR, Osmund C, et al.: Fetal and placental size and risk of hypertension in adult life. BMJ 1990, 301: 259–262.

    Article  PubMed  CAS  Google Scholar 

  76. Whincup PH, Cook DG, Shaper AG: Early influences on blood pressure: a study of children aged 5–7 years. BMJ 1989, 299: 587–591.

    Article  PubMed  CAS  Google Scholar 

  77. Lauer RM, Anderson AR, Beaglehole R, et al.: Factors related to tracking of blood pressure in children: U.S. National Center for Health Statistics Health Examination Surveys Cycles II and III. Hypertension 1984, 6: 307–314.

    Article  PubMed  CAS  Google Scholar 

  78. Krieger DR, Landsberg L: Obesity and hypertension. In Hypertension: Pathophysiology, Diagnosis, and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press, Ltd; 1990: 1741–1757.

    Google Scholar 

  79. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989, 149: 1514–1520.

    Article  PubMed  CAS  Google Scholar 

  80. Rocchini AP, Key J, Bondie D, et al.: The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989, 321: 580–585.

    Article  PubMed  CAS  Google Scholar 

  81. Stevens VJ, Corrigan SA, Obarzanek E, et al.: Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. Arch Intern Med 1993, 153: 849–858.

    Article  PubMed  CAS  Google Scholar 

  82. Light KC, Koepke JP, Obrist PA, et al.: Psychological stress induces sodium and fluid retention in men at high risk for hypertension. Science 1983, 220: 429–431.

    Article  PubMed  CAS  Google Scholar 

  83. Evans WE, Relling MV: Pharmacogenomics: translating functional genomics into rational therapeutics. Science 1999, 286: 487–491.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Alan B. Weder
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harvard Medical School, Department of Medicine, Brigham and Women’s Hospital, Boston, Massachusetts, USA

    Norman K. Hollenberg MD, PhD (Professor of Radiology Director, Physiologic Research) (Professor of Radiology Director, Physiologic Research)

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer Science+Business Media New York

About this chapter

Cite this chapter

Weder, A.B. (2001). Pathogenesis of Hypertension: Genetic and Environmental Factors. In: Hollenberg, N.K. (eds) Atlas of Heart Diseases. Atlas of Heart Diseases. Current Medicine Group, London. https://doi.org/10.1007/978-1-4684-6909-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-6909-7_1

  • Publisher Name: Current Medicine Group, London

  • Print ISBN: 978-1-4684-6911-0

  • Online ISBN: 978-1-4684-6909-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation